Biotech Bullish Stocks: Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), Reliv International, Inc (NASDAQ:RELV), Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX)

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) has seen a massive down tick in the past few trading sessions, and analysts believe that this downward trajectory might continue for the stock and may lead it to lower levels. Short term traders can short the stock at current levels with a tight stop loss at $11 for targets of $8 or lower. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was 5.60% in last session and finished the day at $9.62. Traded volume was 33,551.00million shares in the last session and the average volume of the stock remained 165.66K shares.

Reliv International Inc (NASDAQ:RELV) paid Chief Executive Robert Montgomery $734,586 last year, 2.4 percent less than he earned in 2012. Montgomery’s salary was flat at $642,625 and his bonus declined slightly to $11,396. He also received stock options valued at $8,704 and perquisites that included $39,000 worth of life insurance and a company car valued at $18,229. Reliv International, Inc (NASDAQ:RELV) rose 7.18 percent to $2.24 Wednesday on volume of 39,502.00million shares. The intra-day range of the stock was $2.09 to $2.40. Reliv International, Inc (NASDAQ:RELV) has a market capitalization of $28.37million.

The Compensation Committee of the Board of Directors of Recro Pharma, Inc. (NASDAQ:REPH) approved the grant of annual cash incentive bonuses and stock options to the Company’s executive officers in connection with their service to the Company during the fiscal year ended December 31, 2013. Recro Pharma Inc (NASDAQ:REPH)’s stock on Apr 23, 2014 reported a increase of 24.35% to the closing price of $7.15. Its fifty two weeks range is $5.01 -$9.88. The total market capitalization recorded $55.11million. The overall volume in the last trading session was 72,760.00million shares. In its share capital, REPH has 7.71million outstanding shares.

Zacks assumed coverage on shares of Ignyta Inc (NASDAQ:RXDX) in a report released on Wednesday, Analyst Ratings reports. The firm issued a hold rating on the stock. On Wednesday, shares of Ignyta Inc (NASDAQ:RXDX) advanced 11.30% to close the day at $7.29. Company monthly performance is recorded as -23.90%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone